tradingkey.logo

2Seventy Bio Enters Into Agreement To Be Acquired By Bristol Myers Squibb at $5.00 Per Share

ReutersMar 11, 2025 2:20 AM

- 2Seventy Bio Inc TSVT.O:

  • 2SEVENTY BIO ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY BRISTOL MYERS SQUIBB

  • 2SEVENTY BIO INC - DEAL VALUED AT $5.00 PER SHARE, ALL-CASH TRANSACTION

  • 2SEVENTY BIO INC - TOTAL EQUITY VALUE OF APPROXIMATELY $286 MILLION

  • 2SEVENTY BIO INC - DEAL REPRESENTS 88% PREMIUM TO CLOSING PRICE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI